Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03329950
Title A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celldex Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.